for the following products
Olmesartan Medoxomil EP Impurity C | Olmesartan medoxomil impurity I and Olmesartan Medoxomil EP Impurity C (Dehydro Impurity), RNH-6373
We are one of the world leading companies in manufacturing pharmaceutical standards, including stable-isotope labeled internal standards, metabolites, degradation compounds/impurities, and inhibitor reference compounds. Our products are widely used in Bioanalysis (BA) for preclinical/early stage clinical studies and Bioequivalence (BE) studies for generic drug development.